Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. A. Omrane"'
Autor:
R. Berti, L. Miguel Telega, N. Steinacker, L. C. Domogalla, M. A. Omrane, G. Blazhenets, L. Frings, J. Brumberg, V. A. Coenen, P. T. Meyer, M. D. Döbrössy, A. C. Eder
Publikováno v:
61. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cb13356372ecc5cb88b3bdc94b141ea
https://doi.org/10.1055/s-0043-1766203
https://doi.org/10.1055/s-0043-1766203
Autor:
Lucia Feni, M. Aymen Omrane, Moritz Fischer, Boris D. Zlatopolskiy, Bernd Neumaier, Ines Neundorf
Publikováno v:
Pharmaceuticals, Vol 10, Iss 4, p 99 (2017)
Since pancreatic cancer is often diagnosed in a late state of cancer development, diagnostic opportunities allowing early disease detection are highly sought after. As such, cancer expression of claudin proteins is markedly dysregulated, making it an
Externí odkaz:
https://doaj.org/article/e8242d31b6ec4c788461e80a72c513b3
Autor:
Boris D. Zlatopolskiy, Bernd Neumaier, Moritz Fischer, Lucia Feni, Ines Neundorf, M. Aymen Omrane
Publikováno v:
Pharmaceuticals; Volume 10; Issue 4; Pages: 99
Pharmaceuticals, Vol 10, Iss 4, p 99 (2017)
Pharmaceuticals
Pharmaceuticals 10(4), 99-(2017). doi:10.3390/ph10040099
Pharmaceuticals, Vol 10, Iss 4, p 99 (2017)
Pharmaceuticals
Pharmaceuticals 10(4), 99-(2017). doi:10.3390/ph10040099
Since pancreatic cancer is often diagnosed in a late state of cancer development, diagnostic opportunities allowing early disease detection are highly sought after. As such, cancer expression of claudin proteins is markedly dysregulated, making it an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58ba10c30cc42712f15ebdd2bfcceda